Pages that link to "Q69490075"

The following pages link to Reevaluation of renal tubular glucose transport inhibition by phlorizin analogs (Q69490075):

Displaying 31 items.

• Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents (Q28074843) (← links)
• High affinity phlorizin receptor sites and their relation to the glucose transport mechanism in the proximal tubule of dog kidney (Q28336706) (← links)
• Remogliflozin etabonate, a selective inhibitor of the sodium‐dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients (Q33451134) (← links)
• Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes (Q35214420) (← links)
• Glucose transport in the kidney (Q35307595) (← links)
• Phlorizin: a review (Q35998639) (← links)
• Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus (Q36345951) (← links)
• Sodium, phosphate, glucose, bicarbonate, and alanine interactions in the isolated proximal convoluted tubule of the rabbit kidney (Q37030859) (← links)
• The renal effects of SGLT2 inhibitors and a mini-review of the literature (Q37632127) (← links)
• SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes (Q37864206) (← links)
• Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus (Q38005020) (← links)
• Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport (Q38201162) (← links)
• Sodium-coupled hexose transport (Q38732803) (← links)
• Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus (Q39300071) (← links)
• Carrier-mediated transfer of d-glucose in brush border vesicles derived rom rabbit renal tubules. Na -dependent versus Na -independent transfer (Q39740502) (← links)
• High-level expression of Na /D-glucose cotransporter (SGLT1) in a stably transfected Chinese hamster ovary cell line (Q41009579) (← links)
• Sodium glucose co-transporter inhibitors - A new class of old drugs (Q41872563) (← links)
• Similarity in effects of Na gradients and membrane potentials on D-glucose transport by, and phlorizin binding to, vesicles derived from brush borders of rattit intestinal mucosal cells (Q44092927) (← links)
• Electrophysiological characterization of a recombinant human Na -coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes (Q44934641) (← links)
• Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity. (Q55080603) (← links)
• Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes (Q64066052) (← links)
• Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population (Q64069337) (← links)
• Structre and function of parasite surface membranes—I. Mechanism of phlorizin inhibition of hexose transport by the cestode Hymenolepis diminuta (Q66918793) (← links)
• Sugar uptake into brush border vesicles from dog kidney. I. Specificity (Q67273609) (← links)
• Energy-dependence of phlorizin binding to isolated renal microvillus membranes. Evidence concerning the mechanism of coupling between the electrochemical Na gradient the sugar transport (Q67356895) (← links)
• Renal tubular mechanisms of organic solute transport (Q67758900) (← links)
• [Anatomy of the epithelium. Analysis of transport through the proximal kidney tubule] (Q68513006) (← links)
• Transepithelial transport in cell culture: stoichiometry of Na/phlorizin binding and Na/D-glucose cotransport. A two-step, two sodium model of binding and translocation (Q70640385) (← links)
• Glucose-dependent respiration in suspensions of rabbit cortical tubules (Q71362660) (← links)
• The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat (Q72534735) (← links)
• The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes (Q91012614) (← links)